WP1 is about the management of the project where project activities are coordinated
to ensure timely achievement of the objectives within the budget and time frame. In WP1,
we will also support to train the next generation of scientists.
WP2
Title: Sample collection
WP2 is dedicated to the identification of novel early biomarkers and therapy targets in
AD. To achieve the goals, WP2 is divided into 3 sub-WPs. WP2.1 is about recruiting and
sampling AD patients and controls. Their samples (blood and CSF, respectively) will be
analysed in WP2.2. Together with sample analysis, WP2.2 will also be dedicated to carry out
in vitro and in vivo preclinical studies to target validation and to perform druggability
assessment. Data obtained from preclinical models and from AD patients will be analysed in
WP2.3.
WP3
Title: Dissemination and exploitation of results
We will disseminate and exploit results in WP3. In the frame of WP3, MetaboAD
consortium will involve relevant stakeholders, publicate results to the scientific and non-
scientific communities and to investigate potential business opportunities.